Coronavirus Disease 2019 (COVID-19) Vaccines Market Forecast to 2026

Coronavirus Disease 2019 (COVID-19) Vaccines Market Forecast to 2026

Summary

This publication is an update and extension to the Excel model containing the patient-based sales forecast for COVID-19 vaccines, which was previously covered in Coronavirus Disease 2019 (COVID 19) Vaccines: Opportunity Assessment and Forecast to 2026, published in June 2021.

Report deliverables include a PowerPoint report and an interactive Excel-based forecast model
Forecasts includes 7MM (US, France, Germany, Italy, Spain, UK, and Japan)
Forecasts cover 5 years from 2021 to 2026

the publisher forecast three different potential scenarios for the future use of COVID-19 vaccines -

• The first scenario assumes that annual vaccination with a COVID-19 vaccine will be needed.
• The second scenario assumes annual vaccination for the high-risk population of people 65 years of age and older, while everyone below 65 years of age will need a vaccine only every two years.
• In the third scenario, the high-risk population of people 65 years of age and older will receive a COVID-19 vaccine every two years, while everyone below 65 years will need a vaccine only every five years.

Scope

This report includes -

• Executive Summary
• Disease Overview: History of the outbreak, Etiology and Pathophysiology
• Epidemiology
• Current Vaccination Options: Includes detailed product profiles with SWOT analysis
• Unmet Need and Opportunities: Detailing the major unmet needs with significant KOL insights
• Pipeline Assessment: Includes pipeline overview and detailed product profiles with SWOT analysis
• R&D Strategies: Trends in Clinical Trial Design for COVID-19 Vaccines and Trends in Deal-Making
• Market Outlook

Reasons to Buy

• To understand the current COVID-19 vaccine situation in multiple regions.
• Develop business strategies by understanding the trends shaping and driving the 7MM COVID-19 vaccine.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global COVID-19 vaccine market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.